IEG Policy is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s acting chief says FDA will stay course on current priorities despite change in leadership

Sharpless touches on CBD, nutrition and food safety priorities

This article is powered by Food Chemical News

Though it has changed leadership, FDA will not pause its ongoing projects or make any significant departures from its current priorities and course of action, FDA’s new Acting Commissioner Norman “Ned” Sharpless said in his first major public appearance on Thursday (May 2).

Advertisement

Related Content

Topics

What to read next

UsernamePublicRestriction

Register

PL220104

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel